Optimal CTO Madrid | 2018Course Programme

Thursday 31st May Friday 1st June

DAY 1 THURSDAY 31ST MAY

08:45 – 09:10 Introduction and summary of 2017 cases

J Spratt

09:10 – 09:25 Indications for revascularisation: patient selection

S Rinfret

09:25 – 09:40 CTO physiology: the role of collaterals, defining viability & ischaemia

M McEntegart

09:40 – 09:55 CTO Pathology: how should this affect strategy

A Bagnall

09:55 – 10:10 Fundamentals for CTO success W Wilson

10:10 – 10:15 Introduction to Hybrid J Strange

10:15 – 10:45 Coffee break

10:45 – 12:30 Live cases 1 & 2

Live case operators

Case 1. J Escaned / J Hill

In lab moderator: J Dens

Case 2. C Hanratty / N Gonzalo

In lab moderator: A Grantham

Chair: J Spratt Co-chair: J Goicolea Panel: K Nasu, A Avran, A Nap, A Becker, L Padilla, Y Kashima

12:30 – 13:30 Lunch

13:30 – 13:45Optimal angiography and imaging: defining & explaining the hybrid approach

D Karmpaliotis

13:45 – 14:00

When should you consider a retrograde approach – when could a retrograde approach be hazardous?

T Ramunddal

14:00 – 14:15

When should you consider an antegrade dissection re-entry (ADR) approach – when could ADR be hazardous?

M Wyman

14:15 – 14:20 Wire selection for AWE K Mashayekhi

14:20 – 16:15 Live cases 3 & 4

Live case operators

Case 3. M Yamane / L Nombela-Franco

In lab moderator: E Smith

Case 4. J Spratt / P Salinas

In lab moderator: J Strange

Chair: B Lombardi Co-chair: A Oksness Panel: J Brum Silveira, B Vaquerizo, C Zambekedes, A Gagnor, S Ojeda, K Tammam

16:15 – 16:30Setting standards, ensuring safety & defining quality

C Hanratty

16:30 – 16:45Robotically assisted CTO PCI: ready or not here it comes

A Grantham

16:45 – 17:00The impact of the internet on medical education: from open access to social media

P Meier

17:00 Close Day 1

Course Programme

DAY 2 FRIDAY 1ST JUNE

09:00 – 09:15 Introduction & Objectives C Buller

09:15 – 09:30CTO and multi-vessel revascularisation

D Foley

09:30 – 09:45 Retrograde troubleshooting C Eek

9:45 – 10:00 Coffee break

10:00 – 12:00 Live cases 5 & 6

Live case operators

Case 5. B Lombardi / J Escaned

In lab moderator: D Kefei

Case 6. S Walsh / L Nombela-Franco

In lab moderator: B Faurie

Chair: C Buller Co-chair: D FoleyPanel: G Olivecrona, R Garbo, J Rumoroso, M Sabaté, J Spratt, M Mohandes

12:00 – 12:15CTO PCI in patients with impaired left ventricular function: defining the role of left ventricular support

T de Martini

12:15 – 12:20 BASE and S-BASE J Hill

12:30 – 13:30 Lunch

13:30 – 13:45Complication management – how to deal with life - threatening complications

H Noor

13:45 – 14:00Intravascular imaging; defining its role within CTO PCI

J Escaned

14:00 – 14:15Dual-lumen catheters, luxury or necessity?

J Spratt

14:15 – 14:20 Facilitated ADR M Wyman

14:20 – 14:30Intravascular lithotripsy: current and future role in CTO therapy

T Brinton

14:30 – 16:15 Live cases 7 & 8

Live case operators

Case 7. T DeMartini / P Salinas

In lab moderator: J Irving

Case 8. P Knappen / N Gonzalo

In lab moderator: A Gagnor

Chair: D Karmpaliotis Co-chair: G Sianos Panel: R Jussila, I Gudmundsdottir, P Cardoso, A Lucking, J Fernández-Díaz, L Teruel

16:15 – 16:30What CTO’s should NOT be recanalised?

C Buller

16:30 – 16:45CTO PCI within the post CABG environment

J Dens

16:45 – 17:00Ensuring a durable result –stent optimization and dealing with outflow tract disease

S Walsh

17:00 Meeting summary & close

1576 A4 Programme VP advert.indd 2 16/05/2018 09:50